-
1
-
-
0024552429
-
Clinical epidemiology of endometriosis and infertility
-
Guzick DS: Clinical epidemiology of endometriosis and infertility. Obstet Gynecol Clin No Am 16:43-59, 1989
-
(1989)
Obstet Gynecol Clin No Am
, vol.16
, pp. 43-59
-
-
Guzick, D.S.1
-
2
-
-
0028964109
-
Hormonal regulation of endometriosis and the rationales and effects of gonadotropin-releasing hormone agonist treatment: A review
-
Bergqvist IA: Hormonal regulation of endometriosis and the rationales and effects of gonadotropin-releasing hormone agonist treatment: a review. Hum Reprod 10:446-452, 1995
-
(1995)
Hum Reprod
, vol.10
, pp. 446-452
-
-
Bergqvist, I.A.1
-
3
-
-
0026098581
-
Gonadotropin-releasing hormone and its analogues
-
Conn PM, Crowley WFJ: Gonadotropin-releasing hormone and its analogues. N Engl J Med 324:93, 1991
-
(1991)
N Engl J Med
, vol.324
, pp. 93
-
-
Conn, P.M.1
Crowley, W.F.J.2
-
4
-
-
0024231955
-
LHRH analogues: Their clinical physiology and delivery systems
-
Fraser HM: LHRH analogues: their clinical physiology and delivery systems. Baillieres Clin Obstet Gynecol 2:639, 1988
-
(1988)
Baillieres Clin Obstet Gynecol
, vol.2
, pp. 639
-
-
Fraser, H.M.1
-
5
-
-
0022665939
-
Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: Rationale and perspective
-
Karten MJ, Rivier JE: Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr Rev 7:44, 1986
-
(1986)
Endocr Rev
, vol.7
, pp. 44
-
-
Karten, M.J.1
Rivier, J.E.2
-
6
-
-
0015251023
-
Primary structure of ovine hypothalamic luteinizing hormone factor (LRF)
-
Burgus R, Butcher M, Amoss M, et al: Primary structure of ovine hypothalamic luteinizing hormone factor (LRF). Proc Natl Acad Sci USA 69:278, 1972
-
(1972)
Proc Natl Acad Sci USA
, vol.69
, pp. 278
-
-
Burgus, R.1
Butcher, M.2
Amoss, M.3
-
7
-
-
0015231127
-
Structure of the porcine LH- And FSH-releasing hormone: I. the proposed amino acid sequence
-
Matsuo H, Baba Y, Nair RM, et al: Structure of the porcine LH- and FSH-releasing hormone: I. The proposed amino acid sequence. Biochem Biophis Res Commun 43:1334, 1971
-
(1971)
Biochem Biophis Res Commun
, vol.43
, pp. 1334
-
-
Matsuo, H.1
Baba, Y.2
Nair, R.M.3
-
8
-
-
0018848036
-
The neuroendocrine control of the menstrual cycle
-
Knobil E: The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36:53-88, 1980
-
(1980)
Recent Prog Horm Res
, vol.36
, pp. 53-88
-
-
Knobil, E.1
-
9
-
-
0020532179
-
Clinical applications of LHRH and its analogues
-
Sandow J: Clinical applications of LHRH and its analogues. Clin Endocrinol (Oxf) 18:571, 1983
-
(1983)
Clin Endocrinol (Oxf)
, vol.18
, pp. 571
-
-
Sandow, J.1
-
10
-
-
17144467338
-
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists
-
Labrie F, Belanger A, Kelly PA, et al: Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists. Prog Clin Biol Res 74:273, 1981
-
(1981)
Prog Clin Biol Res
, vol.74
, pp. 273
-
-
Labrie, F.1
Belanger, A.2
Kelly, P.A.3
-
11
-
-
0019943192
-
Danazol in the treatment of endometriosis: Analysis of 100 cases with a 4-year follow-up
-
Barbieri RL, Evans S, Kistner RW: Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril 36:737-747, 1982
-
(1982)
Fertil Steril
, vol.36
, pp. 737-747
-
-
Barbieri, R.L.1
Evans, S.2
Kistner, R.W.3
-
12
-
-
0021949970
-
Treatment of endometriosis with danazol: Report of a six year prospective study
-
Buttram VC, Reiter RC, Ward S: Treatment of endometriosis with danazol: report of a six year prospective study. Fertil Steril 43:353, 1985
-
(1985)
Fertil Steril
, vol.43
, pp. 353
-
-
Buttram, V.C.1
Reiter, R.C.2
Ward, S.3
-
13
-
-
0024204055
-
Gonadotropin releasing hormone (GnRH) agonists in the management of endometriosis: A review
-
Henzl MH: Gonadotropin releasing hormone (GnRH) agonists in the management of endometriosis: a review. Clin Obstet Gynecol 31:840-856, 1988
-
(1988)
Clin Obstet Gynecol
, vol.31
, pp. 840-856
-
-
Henzl, M.H.1
-
14
-
-
0023864757
-
Administration of nasal nafarelin as compared with oral danazol for endometriosis
-
Henzl MR, Corson SL, Moghissi K, et al: Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med 318:485-489, 1988
-
(1988)
N Engl J Med
, vol.318
, pp. 485-489
-
-
Henzl, M.R.1
Corson, S.L.2
Moghissi, K.3
-
15
-
-
0022034741
-
Revised American Fertility Society Classification of endometriosis
-
The American Fertility Society: Revised American Fertility Society Classification of endometriosis. Fertil Steril 43:351, 1985
-
(1985)
Fertil Steril
, vol.43
, pp. 351
-
-
-
16
-
-
0026576010
-
Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up
-
Nafarelin European Endometriosis Trial Group (NEET): Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. Fertil Steril 57:514-522, 1992
-
(1992)
Fertil Steril
, vol.57
, pp. 514-522
-
-
-
17
-
-
0025763359
-
A comparative treatment trial of endometriosis using the gonadotropin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol
-
Fraser IS, Shearman RP, Jansen RP, Sutherland PD: A comparative treatment trial of endometriosis using the gonadotropin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust N Z J Obstet Gynaecol 31:158-163, 1991
-
(1991)
Aust N Z J Obstet Gynaecol
, vol.31
, pp. 158-163
-
-
Fraser, I.S.1
Shearman, R.P.2
Jansen, R.P.3
Sutherland, P.D.4
-
18
-
-
0342684678
-
A comparative study between buserelin and danazol in the treatment of endometriosis
-
Matta MH, Shaw RW: A comparative study between buserelin and danazol in the treatment of endometriosis. Br J Clin Pract 41(suppl 48):64, 1987
-
(1987)
Br J Clin Pract
, vol.41
, Issue.SUPPL. 48
, pp. 64
-
-
Matta, M.H.1
Shaw, R.W.2
-
19
-
-
0024418946
-
Buserelin versus danazol in the treatment of endometriosis-associated infertility
-
Fedele L, Bianchi S, Arcaini L, et al: Buserelin versus danazol in the treatment of endometriosis-associated infertility. Am J Obstet Gynecol 161:871-876, 1989
-
(1989)
Am J Obstet Gynecol
, vol.161
, pp. 871-876
-
-
Fedele, L.1
Bianchi, S.2
Arcaini, L.3
-
20
-
-
0025138807
-
A comparison of the efficiency and safety of buserelin vs danazol in the treatment of endometriosis
-
Protocol 310 Study Group
-
Dawood MY, Spellacy WN, Dmowski WP, et al: A comparison of the efficiency and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. Prog Clin Biol Res 323:253-267, 1990
-
(1990)
Prog Clin Biol Res
, vol.323
, pp. 253-267
-
-
Dawood, M.Y.1
Spellacy, W.N.2
Dmowski, W.P.3
-
21
-
-
0025005019
-
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: A randomized placebo-controlled double-blind study
-
Dlugi AM, Miller JD, Knittle J: Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized placebo-controlled double-blind study. Fertil Steril 54:419-427, 1990
-
(1990)
Fertil Steril
, vol.54
, pp. 419-427
-
-
Dlugi, A.M.1
Miller, J.D.2
Knittle, J.3
-
22
-
-
0026446444
-
Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter double-blind randomized clinical trial. I. Efficacy results
-
Wheeler JM, Knittle JD, Miller JD, Lupron Endometriosis Study Group: Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter double-blind randomized clinical trial. I. Efficacy results. Am J Obstet Gynecol 167:1367-1371, 1992
-
(1992)
Am J Obstet Gynecol
, vol.167
, pp. 1367-1371
-
-
Wheeler, J.M.1
Knittle, J.D.2
Miller, J.D.3
-
23
-
-
0027279278
-
Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter double-blind randomized clinical trial. II. Assessment of safety
-
Wheeler JM, Knittle JD, Miller JD, Lupron Endometriosis Study Group: Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter double-blind randomized clinical trial. II. Assessment of safety. Am J Obstet Gynecol 169:26-33, 1993
-
(1993)
Am J Obstet Gynecol
, vol.169
, pp. 26-33
-
-
Wheeler, J.M.1
Knittle, J.D.2
Miller, J.D.3
-
24
-
-
0025685433
-
Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analogue: Endocrine and clinical results
-
Venturini PL, Anserini P, Fasce V, et al: Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analogue: endocrine and clinical results. Fertil Steril 54:1021-1027, 1990
-
(1990)
Fertil Steril
, vol.54
, pp. 1021-1027
-
-
Venturini, P.L.1
Anserini, P.2
Fasce, V.3
-
25
-
-
0026772450
-
Goserelin (Zoladex) depot in the treatment of endometriosis
-
Reichel RP, Schweppe K-W, Zoladex Endometriosis Study Group: Goserelin (Zoladex) depot in the treatment of endometriosis. Fertil Steril 57:1197-1202, 1992
-
(1992)
Fertil Steril
, vol.57
, pp. 1197-1202
-
-
Reichel, R.P.1
Schweppe, K.-W.2
-
26
-
-
0026663472
-
An open randomized comparative study of the effect of goserelin depot in the treatment of endometriosis
-
Shaw RW, Zoladex Endometriosis Study Team: An open randomized comparative study of the effect of goserelin depot in the treatment of endometriosis. Fertil Steril 58:265-272, 1992
-
(1992)
Fertil Steril
, vol.58
, pp. 265-272
-
-
Shaw, R.W.1
-
27
-
-
0027292330
-
Zoladex (goserelin acetate implant) in the treatment of endometriosis: A randomized comparison with danazol
-
Rock JA, Truglia JA, Caplan RJ, Zoladex Endometriosis Study Group: Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol 82:198-205, 1993
-
(1993)
Obstet Gynecol
, vol.82
, pp. 198-205
-
-
Rock, J.A.1
Truglia, J.A.2
Caplan, R.J.3
-
29
-
-
0026810438
-
The role of GnRH analogues in the treatment of endometriosis
-
Shaw RW: The role of GnRH analogues in the treatment of endometriosis. Br J Obstet Gynecol 99(suppl.):9-12, 1992
-
(1992)
Br J Obstet Gynecol
, vol.99
, Issue.SUPPL.
, pp. 9-12
-
-
Shaw, R.W.1
-
30
-
-
0024380709
-
Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol
-
Burry KA, Patton PE, Illingworth DR: Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol. Am J Obstet Gynecol 160:1454-1461, 1989
-
(1989)
Am J Obstet Gynecol
, vol.160
, pp. 1454-1461
-
-
Burry, K.A.1
Patton, P.E.2
Illingworth, D.R.3
-
31
-
-
0024409020
-
Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis
-
Valimaki M, Nilsson CG, Roine R, Ylikorkala O: Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis. J Clin Endocrinol Metab 69:1097-1103, 1989
-
(1989)
J Clin Endocrinol Metab
, vol.69
, pp. 1097-1103
-
-
Valimaki, M.1
Nilsson, C.G.2
Roine, R.3
Ylikorkala, O.4
-
32
-
-
0025057244
-
Effect of nafarelin versus danazol on lipids and calcium metabolism
-
Bergquist C: Effect of nafarelin versus danazol on lipids and calcium metabolism. Am J Obstet Gynecol 162:589-591, 1990
-
(1990)
Am J Obstet Gynecol
, vol.162
, pp. 589-591
-
-
Bergquist, C.1
-
33
-
-
0023886645
-
A comparison of the effects of buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis
-
Dlugi AM, Rufo S, D'Amico JF, Seibel MM: A comparison of the effects of buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis. Fertil Steril 49:913-916, 1988
-
(1988)
Fertil Steril
, vol.49
, pp. 913-916
-
-
Dlugi, A.M.1
Rufo, S.2
D'Amico, J.F.3
Seibel, M.M.4
-
34
-
-
0025605407
-
Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis
-
Ylikorkala O, Nilsson CG, Hirvonen E, Viinikka L: Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. Gynecol Endocrinol 4:251-260, 1990
-
(1990)
Gynecol Endocrinol
, vol.4
, pp. 251-260
-
-
Ylikorkala, O.1
Nilsson, C.G.2
Hirvonen, E.3
Viinikka, L.4
-
35
-
-
0027531984
-
Impact of medical treatment of endometriosis on bone mass
-
Dawood MY: Impact of medical treatment of endometriosis on bone mass. Am J Obstet Gynecol 168:674-684, 1993
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 674-684
-
-
Dawood, M.Y.1
-
36
-
-
0023255634
-
LHRH analogues and bone loss
-
Devogelaer J-P, Nagant de Deuxchaisnes C, Donnez J, Thomas K: LHRH analogues and bone loss. Lancet 1:1498, 1987
-
(1987)
Lancet
, vol.1
, pp. 1498
-
-
Devogelaer, J.-P.1
De Nagant Deuxchaisnes, C.2
Donnez, J.3
Thomas, K.4
-
37
-
-
0023741271
-
The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism
-
Johansen JS, Riis BJ, Hassager C, et al: The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. J Clin Endocrinol Metab 67:701-706, 1988
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 701-706
-
-
Johansen, J.S.1
Riis, B.J.2
Hassager, C.3
-
38
-
-
0023766048
-
Reversible trabecular bone density loss following induced hypo-estrogenism with GnRH analogue buserelin in premenopausal women
-
Matta WH, Shaw RW, Hesp R, Evans R: Reversible trabecular bone density loss following induced hypo-estrogenism with GnRH analogue buserelin in premenopausal women. Clin Endocrinol (Oxf) 29:45-51, 1988
-
(1988)
Clin Endocrinol (Oxf)
, vol.29
, pp. 45-51
-
-
Matta, W.H.1
Shaw, R.W.2
Hesp, R.3
Evans, R.4
-
39
-
-
0024382414
-
Cortical and trabecular bone mineral content in women with endometriosis: Effect of gonadotropin-releasing hormone agonist and danazol
-
Dawood MY, Lewis V, Ramos J: Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol. Fertil Steril 52:21-26, 1989
-
(1989)
Fertil Steril
, vol.52
, pp. 21-26
-
-
Dawood, M.Y.1
Lewis, V.2
Ramos, J.3
-
40
-
-
0024391190
-
Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma
-
Waibel-Treber S, Minne HW, Scharla SH, et al: Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma. Hum Reprod 4:384-388, 1989
-
(1989)
Hum Reprod
, vol.4
, pp. 384-388
-
-
Waibel-Treber, S.1
Minne, H.W.2
Scharla, S.H.3
-
41
-
-
0024790881
-
A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis
-
Stevenson JC, Lees B, Gardner R, Shaw RW: A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis. Horm Res 32:161-163, 1989
-
(1989)
Horm Res
, vol.32
, pp. 161-163
-
-
Stevenson, J.C.1
Lees, B.2
Gardner, R.3
Shaw, R.W.4
-
42
-
-
0025072407
-
The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis
-
Whitehouse RW, Adams JE, Baucroff K, et al: The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.. Clin Endocrinol (Oxf) 33:365-373, 1990
-
(1990)
Clin Endocrinol (Oxf)
, vol.33
, pp. 365-373
-
-
Whitehouse, R.W.1
Adams, J.E.2
Baucroff, K.3
-
43
-
-
0025771969
-
Gonadotropin-releasing hormone agonist therapy and its effect on bone mass
-
Nencioni T, Penotti M, Barbieri-Carones M, et al: Gonadotropin-releasing hormone agonist therapy and its effect on bone mass. Gynecol Endocrinol 5:49-56, 1991
-
(1991)
Gynecol Endocrinol
, vol.5
, pp. 49-56
-
-
Nencioni, T.1
Penotti, M.2
Barbieri-Carones, M.3
-
44
-
-
0026034221
-
Bone mass in endometriosis patients treated with GnRH agonist implant or danazol
-
Dodin S, Lemay A, Maheux R, et al: Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet Gynecol 77:410-415, 1991
-
(1991)
Obstet Gynecol
, vol.77
, pp. 410-415
-
-
Dodin, S.1
Lemay, A.2
Maheux, R.3
-
45
-
-
0026065117
-
Bone mineral density of the lumbar spine in women with endometriosis
-
Lane N, Baptista J, Orwoll E: Bone mineral density of the lumbar spine in women with endometriosis. Fertil Steril 55:537-542, 1991
-
(1991)
Fertil Steril
, vol.55
, pp. 537-542
-
-
Lane, N.1
Baptista, J.2
Orwoll, E.3
-
46
-
-
0028044615
-
Bone density and endometriosis
-
Dochi T, Lees B, Sidhu M, Stevenson JC: Bone density and endometriosis. Fertil Steril 61:175-177, 1994
-
(1994)
Fertil Steril
, vol.61
, pp. 175-177
-
-
Dochi, T.1
Lees, B.2
Sidhu, M.3
Stevenson, J.C.4
-
48
-
-
0028108330
-
Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis
-
Uemura T, Mohri J, Osada H, et al: Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis. Fertil Steril 62:246-250, 1994
-
(1994)
Fertil Steril
, vol.62
, pp. 246-250
-
-
Uemura, T.1
Mohri, J.2
Osada, H.3
-
49
-
-
0027942518
-
Nafarelin therapy in endometriosis: Long-term effects on bone mineral density
-
Orwoll ES, Yuzpe AA, Burry KA, et al: Nafarelin therapy in endometriosis: long-term effects on bone mineral density. Am J Obstet Gynecol 171:1221-1225, 1994
-
(1994)
Am J Obstet Gynecol
, vol.171
, pp. 1221-1225
-
-
Orwoll, E.S.1
Yuzpe, A.A.2
Burry, K.A.3
-
50
-
-
0029981598
-
Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration
-
Taga M, Minaguchi H: Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration. Acta Obstet Gynecol Scand 75:162-165, 1996
-
(1996)
Acta Obstet Gynecol Scand
, vol.75
, pp. 162-165
-
-
Taga, M.1
Minaguchi, H.2
-
51
-
-
0029871339
-
Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment
-
Paoletti AM, Serra GG, Cagnacci A, et al: Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 65:707-710, 1996
-
(1996)
Fertil Steril
, vol.65
, pp. 707-710
-
-
Paoletti, A.M.1
Serra, G.G.2
Cagnacci, A.3
-
52
-
-
0027257459
-
Gonadotropin-releasing hormone agonists: Treatment of endometriosis
-
Barbieri RL: Gonadotropin-releasing hormone agonists: treatment of endometriosis. Clin Obstet Gynecol 36:636-641, 1993
-
(1993)
Clin Obstet Gynecol
, vol.36
, pp. 636-641
-
-
Barbieri, R.L.1
-
53
-
-
49749170890
-
The use of newer progestins in the treatment of endometriosis
-
Kistner RW: The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol 75:264-278, 1958
-
(1958)
Am J Obstet Gynecol
, vol.75
, pp. 264-278
-
-
Kistner, R.W.1
-
54
-
-
0023721919
-
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis
-
Luciano AA, Turksoy RN, Carleo J: Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet Gynecol 72:323-327, 1988
-
(1988)
Obstet Gynecol
, vol.72
, pp. 323-327
-
-
Luciano, A.A.1
Turksoy, R.N.2
Carleo, J.3
-
55
-
-
0017108903
-
Endometriosis therapy with medroxyprogesterone acetate
-
Roland M, Leistein D, Kane R: Endometriosis therapy with medroxyprogesterone acetate. J Reprod Med 17:249-252, 1976
-
(1976)
J Reprod Med
, vol.17
, pp. 249-252
-
-
Roland, M.1
Leistein, D.2
Kane, R.3
-
56
-
-
0017226927
-
Management of endometriosis with oral medroxyprogesterone acetate
-
Moghissi KS, Boyce CR: Management of endometriosis with oral medroxyprogesterone acetate. Obstet Gynecol 47:265-267, 1976
-
(1976)
Obstet Gynecol
, vol.47
, pp. 265-267
-
-
Moghissi, K.S.1
Boyce, C.R.2
-
57
-
-
0016694205
-
Use of medroxyprogesterone acetate to prevent menopausal symptoms
-
Bullock JS, Massey FM, Gambrell RD: Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol 46:165-168, 1975
-
(1975)
Obstet Gynecol
, vol.46
, pp. 165-168
-
-
Bullock, J.S.1
Massey, F.M.2
Gambrell, R.D.3
-
58
-
-
0018820718
-
Oral medroxyprogesterone in the treatment of postmenopausal symptoms
-
Schiff I, Tulchinsky D, Cramer D, Ryan KJ: Oral medroxyprogesterone in the treatment of postmenopausal symptoms. J Am Med Assoc 244:1443-1445, 1980
-
(1980)
J am Med Assoc
, vol.244
, pp. 1443-1445
-
-
Schiff, I.1
Tulchinsky, D.2
Cramer, D.3
Ryan, K.J.4
-
59
-
-
0020414881
-
Effects of progestins on bone metabolism in postmenopausal women
-
Mandel FP, Davidson BJ, Erlik Y, et al: Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med 27:511-514, 1982
-
(1982)
J Reprod Med
, vol.27
, pp. 511-514
-
-
Mandel, F.P.1
Davidson, B.J.2
Erlik, Y.3
-
60
-
-
0021353847
-
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women
-
Lobo RA, McCormick W, Singer F, Roy S: Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol 63:1-5, 1984
-
(1984)
Obstet Gynecol
, vol.63
, pp. 1-5
-
-
Lobo, R.A.1
McCormick, W.2
Singer, F.3
Roy, S.4
-
61
-
-
0020071571
-
A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles
-
Paterson MEL: A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles. Br J Obstet Gynecol 89:464-468, 1982
-
(1982)
Br J Obstet Gynecol
, vol.89
, pp. 464-468
-
-
Paterson, M.E.L.1
-
62
-
-
84942003745
-
Treatment of postmenopausal hyperparathyroidism with norethindrone
-
Horowitz M, Wishart J, Need AG, et al: Treatment of postmenopausal hyperparathyroidism with norethindrone. Arch Intern Med 147:681-685, 1987
-
(1987)
Arch Intern Med
, vol.147
, pp. 681-685
-
-
Horowitz, M.1
Wishart, J.2
Need, A.G.3
-
63
-
-
0022387946
-
Prevention of bone mineral loss in postmenopausal women by norethisterone
-
Abdalla HI, Hart DM, Lindsay R, et al: Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 66:789-792, 1985
-
(1985)
Obstet Gynecol
, vol.66
, pp. 789-792
-
-
Abdalla, H.I.1
Hart, D.M.2
Lindsay, R.3
-
64
-
-
0026501267
-
Hormone treatment of endometriosis: The estrogen threshold hypothesis
-
Barbieri RL: Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 166:740-745, 1992
-
(1992)
Am J Obstet Gynecol
, vol.166
, pp. 740-745
-
-
Barbieri, R.L.1
-
65
-
-
0023973387
-
Malignancy arising in endometriosis associated with unopposed estrogen replacement
-
Reimnitz C, E. B, Nieberg RK, Hacker NF: Malignancy arising in endometriosis associated with unopposed estrogen replacement. Obstet Gynecol 71:444-449, 1988
-
(1988)
Obstet Gynecol
, vol.71
, pp. 444-449
-
-
Reimnitz, C.1
E, B.2
Nieberg, R.K.3
Hacker, N.F.4
-
66
-
-
0028899915
-
Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain
-
Hornstein MD, Yuzpe AA, Burry KA, et al: Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril 63:955-962, 1995
-
(1995)
Fertil Steril
, vol.63
, pp. 955-962
-
-
Hornstein, M.D.1
Yuzpe, A.A.2
Burry, K.A.3
-
67
-
-
0025272586
-
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogeterone acetate
-
Cedars MI, Lu JKH, Meldrum DR, Judd HL: Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogeterone acetate. Obstet Gynecol 75:641-645, 1990
-
(1990)
Obstet Gynecol
, vol.75
, pp. 641-645
-
-
Cedars, M.I.1
Lu, J.K.H.2
Meldrum, D.R.3
Judd, H.L.4
-
68
-
-
0030027358
-
Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis
-
Makarainen L, Ronneberg L, Kauppila A: Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis. Fertil Steril 65:29-34, 1996
-
(1996)
Fertil Steril
, vol.65
, pp. 29-34
-
-
Makarainen, L.1
Ronneberg, L.2
Kauppila, A.3
-
69
-
-
0025366431
-
The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis
-
Surrey ES, Gambone JC, Lu JK, Judd HL: The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril 53:620-626, 1990
-
(1990)
Fertil Steril
, vol.53
, pp. 620-626
-
-
Surrey, E.S.1
Gambone, J.C.2
Lu, J.K.3
Judd, H.L.4
-
70
-
-
0026726227
-
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: A prospective randomized trial
-
Surrey ES, Judd HL: Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab 75:558-563, 1992
-
(1992)
J Clin Endocrinol Metab
, vol.75
, pp. 558-563
-
-
Surrey, E.S.1
Judd, H.L.2
-
71
-
-
0028917615
-
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: The role of cyclic sodium ethidronate and low-dose norethindrone "add-back" therapy
-
Surrey ES, Voigt B, Fournet N, Judd HL: Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium ethidronate and low-dose norethindrone "add-back" therapy. Fertil Steril 63:747-755, 1995
-
(1995)
Fertil Steril
, vol.63
, pp. 747-755
-
-
Surrey, E.S.1
Voigt, B.2
Fournet, N.3
Judd, H.L.4
-
72
-
-
0025334778
-
Intermittent cyclic etidronate treatment of postmenopausal osteoporosis
-
Watts NB, Harris TS, Genant HK, et al: Intermittent cyclic etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79, 1990
-
(1990)
N Engl J Med
, vol.323
, pp. 73-79
-
-
Watts, N.B.1
Harris, T.S.2
Genant, H.K.3
-
73
-
-
0025366467
-
Effect of intermittent cyclic etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
-
Storm T, Thamsborg G, Steiniche T, et al: Effect of intermittent cyclic etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265-1271, 1990
-
(1990)
N Engl J Med
, vol.322
, pp. 1265-1271
-
-
Storm, T.1
Thamsborg, G.2
Steiniche, T.3
-
74
-
-
0025303668
-
Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
-
Riis BJ, Christiansen C, Johansen JS, Jacobson J: Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J Clin Endocrinol Metab 70:920-924, 1990
-
(1990)
J Clin Endocrinol Metab
, vol.70
, pp. 920-924
-
-
Riis, B.J.1
Christiansen, C.2
Johansen, J.S.3
Jacobson, J.4
-
75
-
-
0026786746
-
A randomized doubleblind placebo-controlled trial on the effects on bone metabolism of the combination of nafarelin acetate and norethisterone
-
Eldred JM, Haynes PJ, Thomas EJ: A randomized doubleblind placebo-controlled trial on the effects on bone metabolism of the combination of nafarelin acetate and norethisterone. Clin Endocrinol (Oxf) 37:354-359, 1992
-
(1992)
Clin Endocrinol (Oxf)
, vol.37
, pp. 354-359
-
-
Eldred, J.M.1
Haynes, P.J.2
Thomas, E.J.3
-
76
-
-
0028232355
-
Can hormone replacement therapy be used during medical therapy of endometriosis?
-
Edmonds DK, Howell R: Can hormone replacement therapy be used during medical therapy of endometriosis? Br J Obstet Gynecol 101:24-26, 1994
-
(1994)
Br J Obstet Gynecol
, vol.101
, pp. 24-26
-
-
Edmonds, D.K.1
Howell, R.2
-
77
-
-
0028860573
-
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogenprogestogen add-back therapy in the treatment of endometriosis
-
Kiilholma P, Korhonen M, Tuimala R, et al: Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogenprogestogen add-back therapy in the treatment of endometriosis. Fertil Steril 64:903-908, 1995
-
(1995)
Fertil Steril
, vol.64
, pp. 903-908
-
-
Kiilholma, P.1
Korhonen, M.2
Tuimala, R.3
-
78
-
-
4243691847
-
The efficacy of norethindrone acetate and conjugated equine estrogens combined with a gonadotropin releasing hormone agonist in the management of symptomatic endometriosis: A one-year multicenter trial
-
Surrey E, Hornstein MD, Weisberg G, et al: The efficacy of norethindrone acetate and conjugated equine estrogens combined with a gonadotropin releasing hormone agonist in the management of symptomatic endometriosis: a one-year multicenter trial. J Soc Gynecolog Investig 4:121A, 1997
-
(1997)
J Soc Gynecolog Investig
, vol.4
-
-
Surrey, E.1
Hornstein, M.D.2
Weisberg, G.3
-
79
-
-
0023078397
-
Clinical profile of Org tibolone
-
Tax L, Goorissen EM, Kicovic PM: Clinical profile of Org tibolone. Maturitas 9:(suppl. 1):3-13, 1987
-
(1987)
Maturitas
, vol.9
, Issue.SUPPL. 1
, pp. 3-13
-
-
Tax, L.1
Goorissen, E.M.2
Kicovic, P.M.3
-
80
-
-
0023083159
-
Longterm, placebo-controlled efficacy and safety study of Org tibolone in climacteric women
-
Benedek-Jaszmann LJ: Longterm, placebo-controlled efficacy and safety study of Org tibolone in climacteric women. Maturitas 9:(suppl. 1):25-33, 1987
-
(1987)
Maturitas
, vol.9
, Issue.SUPPL. 1
, pp. 25-33
-
-
Benedek-Jaszmann, L.J.1
-
81
-
-
0030061173
-
The effect of add-back treatment with tibolone (livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)
-
Lindsay PC, Shaw RW, Bennink HJ, Kicovic P: The effect of add-back treatment with tibolone (livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil Steril 65:342-348, 1996
-
(1996)
Fertil Steril
, vol.65
, pp. 342-348
-
-
Lindsay, P.C.1
Shaw, R.W.2
Bennink, H.J.3
Kicovic, P.4
-
82
-
-
0031019505
-
Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis
-
Taskin O, Yalcinoglu AI, Kukuk S, et al: Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis. Fertil Steril 67:40-45, 1997
-
(1997)
Fertil Steril
, vol.67
, pp. 40-45
-
-
Taskin, O.1
Yalcinoglu, A.I.2
Kukuk, S.3
-
83
-
-
0027716654
-
Anabolic actions of parathyroid hormone on bone
-
Dempster DW, Cosman F, Parisien M, et al: Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709, 1993
-
(1993)
Endocr Rev
, vol.14
, pp. 690-709
-
-
Dempster, D.W.1
Cosman, F.2
Parisien, M.3
-
84
-
-
0027985064
-
Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency
-
Finkelstein JS, Klibanski A, Schaefer EH, et al: Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618-1623, 1994
-
(1994)
N Engl J Med
, vol.331
, pp. 1618-1623
-
-
Finkelstein, J.S.1
Klibanski, A.2
Schaefer, E.H.3
-
85
-
-
0029071351
-
Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin
-
Roux C, Pellissier C, Listrat V, et al: Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin. Osteoporosis Int 5:185-190, 1995
-
(1995)
Osteoporosis int
, vol.5
, pp. 185-190
-
-
Roux, C.1
Pellissier, C.2
Listrat, V.3
|